Early-Phase Data Support Novel Contrast Agent - Top-Institutions - MDSpire

Early-Phase Data Support Novel Contrast Agent

ASE 2026 data support further development of MVT-100 in pivotal trials.

  • By

  • Julia Cipriano, MS, CMPP

  • June 27, 2026

  • 3 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Radiology
    • Biomedical Imaging

  • #2

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Radiology
    • Oncology

Original Source(s)

Early-Phase Data Support Novel Contrast Agent

  • by Julia Cipriano, MS, CMPP

  • June 27, 2026

Related Content

AI CAC Scoring Aids Workflow

A single-center editorial described real-world integration of artificial intelligence–based coronary artery calcium scoring into routine cardiac CT workflow, with researchers reporting rapid report availability and high agreement with manual reference standards while emphasizing continued radiologist oversight.

Top 10 Evidence-Based Essentials in Cardiology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

Does Weight Loss Intervention Improve Persistent AF?

Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.